99,404 Shares in Enhabit, Inc. $EHAB Acquired by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC purchased a new stake in shares of Enhabit, Inc. (NYSE:EHAB) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 99,404 shares of the company’s stock, valued at approximately $958,000. Campbell & CO Investment Adviser LLC owned approximately 0.20% of Enhabit at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Jones Financial Companies Lllp grew its holdings in shares of Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after buying an additional 8,879 shares during the last quarter. Strs Ohio purchased a new position in Enhabit in the 1st quarter worth $82,000. CWM LLC lifted its position in Enhabit by 383.6% during the 1st quarter. CWM LLC now owns 11,738 shares of the company’s stock worth $103,000 after acquiring an additional 9,311 shares during the period. Acadian Asset Management LLC purchased a new stake in Enhabit during the 1st quarter valued at about $114,000. Finally, Mackenzie Financial Corp grew its stake in Enhabit by 12.1% during the 1st quarter. Mackenzie Financial Corp now owns 14,468 shares of the company’s stock valued at $127,000 after purchasing an additional 1,564 shares during the last quarter.

Enhabit Trading Up 0.9%

Shares of NYSE:EHAB opened at $8.07 on Thursday. Enhabit, Inc. has a 12-month low of $6.47 and a 12-month high of $10.90. The company has a market capitalization of $408.17 million, a PE ratio of -32.26 and a beta of 1.69. The business has a 50 day moving average of $8.09 and a two-hundred day moving average of $8.39. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.75.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. The business had revenue of $263.60 million for the quarter, compared to analysts’ expectations of $267.08 million. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. As a group, analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. UBS Group decreased their target price on Enhabit from $10.00 to $8.50 and set a “neutral” rating for the company in a report on Friday, August 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Enhabit in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Enhabit presently has a consensus rating of “Hold” and an average price target of $8.67.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.